Animal Drug Compounding Market Expected to Reach $2.5 Billion by 2030 Growing at 7.8% CAGR

April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Acquired Autoimmune Hemolytic Anemia Market During 2026–2030?

The animal drug compounding market has experienced substantial growth in recent years. Its valuation is expected to rise from $1.79 billion in 2025 to $1.91 billion in 2026, driven by a compound annual growth rate (CAGR) of 7.0%. This historical growth can be linked to several factors, including the increasing prevalence of chronic diseases in companion animals, a rise in veterinary clinic visits, the demand for flexible dosage forms, the expansion of the companion animal population, and the growth of veterinary pharmaceutical companies.

The animal drug compounding market is projected to experience substantial expansion in the coming years, reaching $2.58 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.8%. This anticipated growth during the forecast period is driven by factors such as advancements in drug compounding technologies, the growing embrace of AI for personalized medical solutions, an increase in applications for livestock treatment, a heightened understanding of customized veterinary therapies, and the broader integration of veterinary diagnostics. Key trends anticipated for this period encompass a rising demand for personalized veterinary medications, the wider availability of injectable and oral compounded drugs, a stronger emphasis on the well-being of companion animals, the fusion of veterinary diagnostics with drug compounding practices, and the uptake of tailored hormonal and anti-inflammatory treatments.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9964&type=smp

Which Economic Or Industry Drivers Are Impacting The Acquired Autoimmune Hemolytic Anemia Market?

The future expansion of the animal drug compounding market is expected to be propelled by an increase in pet expenditure. This term refers to the overall financial outlay associated with owning and looking after a pet. Pet expenditure fosters the need for personalized medications designed to meet the specific requirements of individual animals, thereby encouraging compounding pharmacies to continue delivering these specialized services in veterinary care. For instance, in October 2023, the North American Pet Health Insurance Association (NAPHIA), a US-based trade organization, published that pet owners in the United States spent $136.8 billion on their dogs, cats, birds, and other companion animals in 2022, and this figure is projected to rise to $143.6 billion in 2023. Therefore, the growing pet expenditure serves as a driving force for the animal drug compounding market.

How Are The Various Segments Of The Acquired Autoimmune Hemolytic Anemia Market Categorized?

The animal drug compounding market covered in this report is segmented –

1) By Animal Type: Companion Animals, Livestock Animals

2) By Product: Anti-Infective Agents, Anti-inflammatory Agents, Hormones And Substitutes, CNS Agents, Other Products

3) By Route Of Administration: Oral, Injectable, Topical, Other Routes Of Administrations

4) By Application: Veterinary Hospitals, Veterinary Clinics, Veterinary Diagnostic Centers

Subsegments:

1) By Companion Animals: Dogs, Cats, Horses

2) By Livestock Animals: Cattle, Swine, Poultry, Sheep, Goats

What Trends Are Affecting The Expansion Of The Animal Drug Compounding Market?

Major companies within the animal drug compounding market are developing innovative products, including feline-friendly formulations, to improve the safety and effectiveness of medications tailored specifically for cats. Feline-friendly formulations refer to products specifically designed to be safe, effective, and appealing for cats. For instance, in September 2024, Wedgewood, a US-based veterinary pharmaceutical company, launched compounded molnupiravir. Compounded molnupiravir is an antiviral drug specifically for treating Feline Infectious Peritonitis (FIP) in cats. It offers feline-friendly formulations of molnupiravir, available in various dosages designed to treat different forms of FIP, including effusive, non-effusive, neurological, and ocular types. This involves producing different dosages and flavors, including flavored oral oil suspensions and capsules, to meet the specific requirements of individual feline patients.

Which Major Firms Influence Developments In The Acquired Autoimmune Hemolytic Anemia Market?

Major companies operating in the animal drug compounding market are Akina Animal Health, Letco Medical LLC, The Pet Apothecary LLC, Vetsource Inc., BCP Veterinary Pharmacy, VetRxDirect LLC, Vetcentric Pty. Ltd., Pet Health Pharmacy, PetRx2Go, PetMed Express Inc., Diamondback Drugs, Brava Veterinary Pharmacy, Veterinary Pharmacies of America, MEDS Canadian Compounding Pharmacy, Chiron Compounding Pharmacy, Dougherty’s Pharmacy, Pace Pharmacy, Aurora Compounding, ESSENTIAL PHARMACY COMPOUNDING VET, SCIRx Pharmacy, Summit Veterinary Pharmacy Ltd, ScriptWorks, Veterinary Specialty Pharmacy, Veterinary Pharmaceutical Solutions, Wedgewood Pharmacy LLC, Hoye’s Pharmacy, Triangle Compounding Pharmacy Inc., Vertisis Custom Pharmacy LLC

Read the full animal drug compounding market report here:

https://www.thebusinessresearchcompany.com/report/animal-drug-compounding-global-market-report

What Are The Top-Performing Regions Within The Acquired Autoimmune Hemolytic Anemia Market?

North America was the largest region in the animal drug compounding market in 2025. The regions covered in the animal drug compounding market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Acquired Autoimmune Hemolytic Anemia Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9964&type=smp

Browse Through More Reports Similar to the Global Animal Drug Compounding Market 2026, By The Business Research Company

Farm Animal Drugs Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/farm-animal-drugs-global-market-report

Companion Animal Pharmaceuticals Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/companion-animal-pharmaceuticals-global-market-report

Animal Medicine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-medicine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795